Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post via Yahoo News· 14 hours agoAll the doctors from his oncology practice would gather in the open-air courtyard under the shadow...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Reuters via Yahoo News· 8 hours agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 11 hours agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
A Startling New Study Found That 75% of Past COVID Patients May Suffer From This Heart Condition
Parade via AOL· 3 days agoChances are, by now you know that COVID-19 is serious. But just in case you didn't—or if you didn't...
Analysis | Unpacking the story of Fauci and painful experiments involving dogs
Washington Post· 17 hours agoWhat you signed off on and these experiments that happened to beagles paid for by the American...
COVID guidelines caused millions to suffer. Now Fauci admits 'there was no science behind it.'
USA TODAY Opinion via Yahoo News· 3 days agoIn January, Fauci told staff and members of the Select Subcommittee on the Coronavirus Pandemic that...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Study: Long COVID remains serious and persistent; more than 200 symptoms identified
FOX30 / CBS47 Jacksonville· 13 hours ago“Long Covid can impact people across the life span, from children to older adults, as well as across...
Whooping cough cases double in the U.S., a potential legacy of the pandemic
Washington Post· 1 day agoWhooping cough, a bacterial illness that poses an especially significant threat to infants, is...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 9 hours agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...